Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
from established collaborations and access to centralized facilities with expertise in functional genomics and cell biology, proteomics, cutting-edge microscopy, immunology, technology development, and
-
researcher to study the complexity and heterogeneity of both mouse and human microglia in neurodevelopment and neurodegeneration. By using state of the art spectral flow cytometry you will develop advanced
-
researcher who is passionate about developing automated systems for microbiological research. The ideal candidate has: An MSc degree in bioengineering, biotechnology, microbiology, computer science, mechanical
-
Participation in a large European collaboration State-of-the-art research facilities A dedicated training program to broaden your expertise and enhance your skill set A doctoral scholarship for a period of one
-
to develop new carbon capture technologies. We are seeking a motivated postdoc to identify biochemical activities in phytoplankton that convert intracellular metabolites into stable, degradation-resistant
-
, an excellence-based research institute KU Leuven, one of Europe’s leading research universities State-of-the-art research facilities An extensive VIB and KU Leuven training program to broaden your
-
most prominent universities, consistently ranked in the top 50 worldwide. Leuven is located 10 miles from Brussels, with frequent direct train connections to Brussels airport. Profile PhD in a
-
(Leuven, Belgium). We are a team of more than 15 international scientists/ admin. staff studying human brain development and disease, combining human stem cell technology, human brain and mouse models. Job
-
in A. thaliana and wheat, which we started to functionally characterize. The Vascular Development group (https://www.derybellab.be), studies plant vascular development at the interface between
-
that underlies cancer initiation, progression and metastatic dissemination with the ultimate goal to develop more effective and specific anti-cancer (combination) therapies. CCB is currently composed